Racial differences in knowledge, attitudes, and sources of information about germline cancer genetic testing in the U.S.A.: An analysis of the health information National Trends Survey System
Alkhatib K, Filipas D, Briggs L, Frego N, Koelker M, Lipsitz S, Pierorazio P, Rebbeck T, Kilbridge K, Kibel A, Trinh Q, Rana H, Cole A
PREV MED. 2024;178:.

Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision-Making
Frego N, Beatrici E, Labban M, Stone B, Filipas D, Koelker M, Lughezzani G, Buffi N, Osman N, Lipsitz S, Sammon J, Kibel A, Trinh Q, Cole A
AM J PREV MED. 2024;66(1):27-36.

Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management
Pose R, Knipper S, Ekrutt J, Kölker M, Tennstedt P, Heinzer H, Tilki D, Langer F, Graefen M
ASIAN J UROL. 2024;11(1):42-47.

Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer
Qian Z, Filipas D, Koelker M, Stone B, Beatrici E, Labban M, Tuncali K, Lipsitz S, Trinh Q, Cole A
CLIN GENITOURIN CANC. 2024;22(6):102184.

Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, Schuettfort V, König F, Gild P, Ludwig T, Marks P, Dahlem R, Fisch M, Shariat S, Vetterlein M
CLIN GENITOURIN CANC. 2024;22(2):336-346.e9.

Can PROMs improve racial equity in outcomes after prostatectomy?
Cole A, Koelker M, Makanjuola J, Moore C
NAT REV UROL. 2023;20(3):125-126.

Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study
Groeben C, Boehm K, Koch R, Sonntag U, Nestler T, Struck J, Heck M, Baunacke M, Uhlig A, Koelker M, Meyer C, Becker B, Salem J, Huber J, Leitsmann M
WORLD J UROL. 2023;41(2):601-609.

MP64-16 THE EFFECT OF INDETERMINATE PATHOLOGIC MARGINS ON SURVIVAL AFTER SURGERY FOR RENAL CELL CARCINOMA
K. F, V. S, RINK M, Edoardo B, Muhieddine L, S. V, W. V, Mara K, Nicola F, P. C, Quoc-Dien T
J UROLOGY. 2023;209(Supplement 4):e887.

Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005
Klemm J, Koelker M, Shariat S, Fisch M, Vetterlein M
EUR UROL FOCUS. 2023 [Epub ahead of print].

Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting
Klemm J, Rink M, von Deimling M, Koelker M, Gild P, Shariat S, Dahlem R, Fisch M, Vetterlein M
EUR UROL FOCUS. 2023;9(6):1072-1076.

Impact of exercise on physical health status in bladder cancer patients
Koelker M, Alkhatib K, Briggs L, Labban M, Meyer C, Dieli-Conwright C, Kang D, Steele G, Preston M, Clinton T, Chang S, Kibel A, Trinh Q, Mossanen M
CUAJ-CAN UROL ASSOC. 2023;17(1):E8-E14.

Rational peri-operative management of antithrombotic therapy in patients undergoing radical cystectomy: A 30-day morbidity analysis based on the updated European Association of Urology guidelines for standardized complication reporting
Koelker M, Bradtke M, Klemm J, von Deimling M, Gild P, Dahlem R, Fisch M, Rink M, Vetterlein M
EJSO-EUR J SURG ONC. 2023;49(12):107123.

Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy
Tan W, Koelker M, Campain N, Cole A, Labban M, Mossanen M, Barod R, Kibel A, Chang S, Bex A, Trinh Q
EUR UROL FOCUS. 2023;9(2):333-335.

Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, König F, Gild P, Khonsari M, Ludwig T, Marks P, Dahlem R, Fisch M, Vetterlein M
BJU INT. 2023;131(1):90-100.

Anesthetic Technique (Spinal vs. General Anesthesia) in Holmium Laser Enucleation of the Prostate: Retrospective Analysis of Procedural and Functional Outcomes among 1,159 Patients
Yu H, Gild P, Pompe R, Vetterlein M, Ludwig T, Soave A, Kölker M, Maurer V, Marks P, Becker A, Punke M, Fisch M, Rink M, Dahlem R, Meyer C
UROL INT. 2023;107(4):336-343.

Auswirkungen der COVID-19 Pandemie auf die urologische Weiterbildung in Deutschland
Aksoy C, Reimold P, Borgmann H, Kölker M, Cebulla A, Struck J, Zehe V, Nestler T, von Landenberg N, Uhlig A, Boehm K, Leitsmann M
AKTUEL UROL. 2022;53(4):317-324.

Association Between Alcohol Intake and Prostate Specific Antigen Screening: Results From a National Behavioral Survey
Frego N, Alkhatib K, Labban M, Koelker M, Lughezzani G, Osman N, Solomon S, Lipsitz S, Trinh Q, Cole A
UROLOGY. 2022;167:115-120.

Körperliche Aktivität von Patientinnen und Patienten mit Blasenkrebs
Koelker M
Uroforum. 2022;36-37.

Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer
Koelker M, Krimphove M, Alkhatib K, Nabi J, Kuo L, Lipsitz S, Choueiri T, Chang S, Doherty G, Kibel A, Trinh Q, Cole A
JAMA NETW OPEN. 2022;5(11):.

Editorial Commentary: Facility-Level Variation in Use of Locoregional Therapy for Metastatic Prostate Cancer
Koelker M, Qian Z, Cole A
Urol Pract. 2022;9(2):149-149.

Re: Christopher Soliman, Niranjan J. Sathianathen, Gianluca Giannarini, et al. There is a Need for a Universal Language in the Reporting and Grading of Complication and Intervention Events to Ensure Comparability and Improvement of Surgical Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.022
Koelker M, Rink M, Vetterlein M
EUR UROL. 2022;81(6):e150-e151.

Urinary Diversion With or Without Concomitant Cystectomy for Benign Conditions: A Comparative Morbidity Assessment According to the Updated European Association of Urology Guidelines on Reporting and Grading of Complications
Vetterlein M, Buhné M, Yu H, Klemm J, von Deimling M, Gild P, Koelker M, Dahlem R, Fisch M, Soave A, Rink M
EUR UROL FOCUS. 2022;8(6):1831-1839.

The Impact of COVID-19 on Cancer Screening and Treatment.
Koelker M, Labban M, Trinh Q
American Urological Association News. 2021;12-13.

The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy
Rink M, Riethdorf S, Yu H, Kölker M, Vetterlein M, Dahlem R, Fisch M, Pantel K, Soave A
J CLIN MED. 2020;9(11):.

Psychometric properties of the German version of Observer OPTION
Kölker M, Topp J, Elwyn G, Härter M, Scholl I
BMC HEALTH SERV RES. 2018;18(1):74.

Letzte Aktualisierung aus dem FIS: 27.11.2024 - 23:33 Uhr